| |
|
|
|
Oxford Global, TBC, Shanghai, China
27-28 January 2015
In keeping with Oxford Global’s highly successful life sciences series, an expert panel of 40 speakers will present a full conference programme covering the topics outlined below. 4th Annual Clinical Development and Trials Asia Congress Day 1– Clinical Development Activities & Clinical Outsourcing Strategies - Regional clinical development activities in Asia and Asia Pacific regions – China, Japan, South Korea & Singapore
- Clinical development activities in oncology and other therapeutic areas
- Selecting the correct Pharma – CRO partnership for maximum success
- Changing regulatory environment in China and impact of this on multinational drug development activities
- Regulatory updates for Registration for Multinational Clinical Trials – China, Japan, South Korea & Singapore
Day 1 – Featured Technology Stream Enabling Technologies for Clinical Development and Personalised Medicine - Imaging biomarkers: bridging preclinical and clinical research
- Medical Imaging technologies
- Implementing biomarkers in early phase clinical trials
- Development of Companion Diagnostics in Clinical Trials
- Biometrics in Asia Pacific Clinical Trials
Day 2 – Clinical Trials Management Strategies in Asia and Asia Pacific Regions - Implementing successful patient recruitment and retention strategies
- Opportunities of bridging studies in Asia for Global Development
- Country and site selection for global clinical trials
- Overcoming regulatory hurdles in Asia and Asia Pacific regions
- Managing clinical trials in oncology and other therapeutic areas
- Ensuring pharmacovigilance and patient safety in clinical trials in Asia
- Clinical supply chain management
- Managing Safety and Efficacy
4th Annual Pharma R&D World Asia Congress Day 1 – Innovation Strategies to Advance R&D in Asia - R&D collaborations between East & West
- Guaranteeing successful outsourcing partnerships
- Successful business models in CRO partnership
- Multi-national pharma companies in emerging markets
- International regulatory updates including FDA breakthrough regulation, EMA RMP regulation
Day 2 – Drug Innovation and Drug Development Activities in Asia - Translational research strategies: discovery to development
- Regulatory considerations for multiregional drug approval
- Targeted Therapy & Molecular Targeted Drugs and
- Developing companion diagnostics for Targeted Therapies
- Drug development in oncology and other therapeutic areas
- Novel methods to accelerate drug development pipeline
- In licensing strategies
|
|
|
|
|
|
|
|
Organized by:
|
|
Oxford Global |
|
|
Invited Speakers:
|
|
2015 Speakers Include: - Yong-jiang Hei
Executive Medical Director, Amgen China - Oliver Kong
Senior Director, Clinical Development Oncology, Celgene Corporation - Zhengqing Li
VP and Head of China Development, MSD - Akhilesh Sharma
Vice President & Global Head Global Medical Affairs, Dr. Reddy's Laboratories India - Jagdev Sidhu
Senior Director Clinical Pharmacology & Pharmacometrics, CSL Limited - Cezary Statuch
Vice President of R&D, Bristol-Myers Squibb, China - Dejun Tang
Biometrics & Statistical Sciences and Methodology, Novartis, China - Wei Wang
Associate Director, Safety Surveillance and Risk Management, Pfizer, China
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
N/A
|
|
|
|
|
|
|
|
Registration:
|
|
To find out more regarding how to book and to enquire about available discounts, please contact Steph Punfield on s.punfield@oxfordglobal.co.uk or call +44 (0)1865 248455.
|
|
|
E-mail:
|
|
s.punfield@oxfordglobal.co.uk
|
|
|
|
|
|
|
|
|